This is a phase III, multicenter, randomized, double-blind study of indinavir sulfate (IDV) with open label zicovudine (ZDV) and lamivudine (3TC) in patients with CD4 counts < 200 and > 6 months of prior ZZDV experience. The study is designed to determine the clinical efficacy of IDV in subjects with advanced HIV disease who have had prior antiviral therapy.
Showing the most recent 10 out of 1085 publications